National Health Investors Inc NHI
Institutional shares held
33.2 Million
8.9K
calls
5.8K
puts
Total value of holdings
$2.56B
$686K
calls
$447K
puts
Market Cap
$3.45B
44,655,200
Shares Out.
Institutional ownership
74.38%
# of Institutions
311
We take great care to ensure that the data presented and summarized in this overview for NATIONAL HEALTH INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHI
View all-
Vanguard Group Inc Valley Forge, PA6.5MShares$501 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.41MShares$340 Million0.01% of portfolio
-
State Street Corp Boston, MA2.02MShares$155 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.64MShares$126 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY1.61MShares$124 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.24MShares$96 Million0.01% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA987KShares$76.1 Million0.81% of portfolio
-
Macquarie Group LTD Australia, C3978KShares$75.5 Million0.09% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA791KShares$61 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC766KShares$59.1 Million0.0% of portfolio
Latest Institutional Activity in NHI
Top Purchases
Top Sells
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Insider Transactions at NHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Charlotte A Swafford Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
62,827
-33.03%
|
$4,900,506
$78.37 P/Share
|
|
Dec 09
2025
|
Charlotte A Swafford Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
80,000
+8.98%
|
$4,880,000
$61.69 P/Share
|
|
Nov 20
2025
|
James R Jobe Director |
SELL
Payment of exercise price or tax liability
|
Direct |
22,135
-41.23%
|
$1,726,530
$78.16 P/Share
|
|
Nov 20
2025
|
James R Jobe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+31.77%
|
$1,725,000
$69.2 P/Share
|
|
Sep 23
2025
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,765
-46.61%
|
$1,661,200
$80.06 P/Share
|
|
Sep 23
2025
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+23.13%
|
$1,587,000
$69.2 P/Share
|
|
May 05
2025
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-0.58%
|
$19,684
$76.04 P/Share
|
|
May 05
2025
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-0.41%
|
$29,944
$76.04 P/Share
|
|
Mar 28
2025
|
Robert G Adams Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
32,935
-8.78%
|
$2,437,190
$74.7 P/Share
|
|
Mar 28
2025
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
45,000
+3.95%
|
$2,475,000
$55.3 P/Share
|
|
Mar 03
2025
|
D. Eric Mendelsohn CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+7.65%
|
-
|
|
Mar 03
2025
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+6.07%
|
-
|
|
Mar 03
2025
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+8.23%
|
-
|
|
Mar 03
2025
|
John L Spaid CFO/EVP Finance |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+12.7%
|
-
|
|
Mar 03
2025
|
David L Travis SVP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+20.33%
|
-
|
|
Feb 23
2025
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.69%
|
$18,156
$68.96 P/Share
|
|
Feb 23
2025
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-0.3%
|
$18,156
$68.96 P/Share
|
|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
12,635
-100.0%
|
-
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,665
-45.65%
|
$4,087,860
$84.66 P/Share
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+17.55%
|
$3,795,000
$69.2 P/Share
|
Last 12 Months Summary
Buy / Acquisition
203K
Shares
From
9
Insiders
| Exercise of conversion of derivative security | 173K shares |
|---|---|
| Grant, award, or other acquisition | 29.5K shares |
Sell / Disposition
140K
Shares
From
6
Insiders
| Payment of exercise price or tax liability | 140K shares |
|---|